Experimental Infection of Richardson’s Ground Squirrels (\u3ci\u3eSpermophilus Richardsonii\u3c/i\u3e ) With Attenuated and Virulent Strains pf \u3ci\u3eBrucella abortus\u3c/i\u3e by Nol, Pauline et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
USDA National Wildlife Research Center - Staff 
Publications 
U.S. Department of Agriculture: Animal and 
Plant Health Inspection Service 
2009 
Experimental Infection of Richardson’s Ground Squirrels 
(Spermophilus Richardsonii ) With Attenuated and Virulent Strains 
pf Brucella abortus 
Pauline Nol 
USDA-APHIS-Wildlife Services, pauline.nol@aphis.usda.gov 
Steven C. Olsen 
USDA, Agricultural Research Service, National Animal Disease Center 
Jack C. Rhyan 
USDA-APHIS-Wildlife Services 
Follow this and additional works at: https://digitalcommons.unl.edu/icwdm_usdanwrc 
 Part of the Environmental Sciences Commons 
Nol, Pauline; Olsen, Steven C.; and Rhyan, Jack C., "Experimental Infection of Richardson’s Ground 
Squirrels (Spermophilus Richardsonii ) With Attenuated and Virulent Strains pf Brucella abortus" (2009). 
USDA National Wildlife Research Center - Staff Publications. 956. 
https://digitalcommons.unl.edu/icwdm_usdanwrc/956 
This Article is brought to you for free and open access by the U.S. Department of Agriculture: Animal and Plant Health 
Inspection Service at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in USDA 
National Wildlife Research Center - Staff Publications by an authorized administrator of DigitalCommons@University 
of Nebraska - Lincoln. 
JOURNAL OF WILDLIFE DISEASES, 45(1), 2009, PP. 189–195
# WILDLIFE DISEASE ASSOCIATION 2009
Experimental Infection of Richardson’s Ground Squirrels
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Brucella abortus
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Plant Health Inspection Service, National Wildlife Research Center, 4101 LaPorte Avenue, Fort Collins, Colorado
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ABSTRACT: A previous investigation of the
safety of Brucella abortus strain RB51
(sRB51) in various nontarget species suggested
that Richardson’s ground squirrels (Spermoph-
ilus richardsonii) may develop persistent infec-
tions when orally inoculated with the vaccine.
In the present study, sRB51, B. abortus strain
19 (s19), and virulent B. abortus strain 9941
(s9941) were administered orally to Richard-
son’s ground squirrels to further characterize B.
abortus infection in this species. Six groups of
nongravid ground squirrels were orally inocu-
lated with 63108 colony forming units (cfu)
sRB51 (n510), 2.53104 cfu s19 (n510),
2.53107 cfu s19 (n56), 1.33106 cfu s9941
(n55), 2.13108 cfu s9941 (n55), or vaccine
diluent (control; n54). One of five animals in
the lower-dose s19 group and two of three
animals in the higher-dose s19 group showed
persistence of bacteria in various tissues at
14 wk postinoculation (PI). At 18 wk PI, one of
five animals in the sRB51 group and one of five
animals in the high-dose s9941 group were
culture positive. Although we did detect some
persistence of B. abortus strains at 18 wk, we
found no evidence of pathology caused by B.
abortus strains in nonpregnant Richardson’s
ground squirrels based on clinical signs, gross
lesions, and microscopic lesions.
Key words: Brucella abortus, brucellosis,
nontarget, Richardson’s ground squirrel, Sper-
mophilus richardsonii, strain 19, strain RB51,
wildlife vaccination.
Brucellosis is a highly important disease
in humans, wildlife, and livestock world-
wide. In the US, bison (Bison bison) and
elk (Cervus elaphus) are considered
sources of Brucella abortus for domestic
cattle in the Greater Yellowstone area
(GYA), which includes portions of the
states of Wyoming, Montana, and Idaho.
Based on epidemiologic evidence, wild elk
have been identified as the source for B.
abortus in an Idaho cattle herd (Hillman,
2002). In addition, both elk and bison are
capable of transmitting B. abortus to cattle
in experimental settings (Davis et al.,
1990; Thorne et al., 2002). Considerable
efforts by numerous researchers have
been devoted to investigating the efficacy
and safety of B. abortus strain RB51
(sRB51), an attenuated rough strain
(Schurig et al., 1991) in wild ungulates.
Strain RB51 is safe for use in bison, and,
although this vaccine has produced mixed
results against abortion in this species
(Elzer et al., 1998; Olsen et al., 1998,
1999; Elzer et al., 2002; Olsen and
Holland, 2003; Olsen et al., 2003), it is
currently being considered for use in
vaccination of bison in Yellowstone Na-
tional Park. In elk, this vaccine does not
appear to provide any protection from
abortion (Cook et al., 2000; Kreeger et al.,
2000). However, recombinant strains of
sRB51 are currently being investigated for
efficacy in elk (P. Nol, unpubl. data).
Research programs involving live vaccines
intended for use in wildlife require that
safety studies be carried out in potential
nontarget species. In such a study, Janus-
zewski and others (2001) noted that
Richardson’s ground squirrels (Spermo-
philus richardsonii), an abundant species
of ground squirrel in the GYA, maintained
persistent infections for 12 wk after oral
inoculation with 7.83107 colony forming
units (cfu) of sRB51 (6/7 and 4/7 were
culture positive in various tissues at 8 and
12 wk, respectively). In addition, 6/10
culture positive squirrels had gross liver
lesions, and one animal had lesions in the
testes, although no clinical signs were
observed, and it was not determined if
these lesions were specifically induced by
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sRB51 infection. The presence of persis-
tent infections and lesions in these animals
was unexpected, as this was not found in
other rodent species tested in this study,
including deer mice (Peromyscus manicu-
latus) and prairie voles (Microtus ochro-
gaster). We were therefore interested in
determining how long various B. abortus
strains (including field strain) could persist
in Richardson’s ground squirrels and
whether any of these strains would induce
pathology. Additional knowledge regard-
ing how Brucella strains may affect this
species would be very useful, not only in
the event that a live attenuated strain of B.
abortus is utilized in a field vaccination
program in the GYA, but also in deter-
mining if this species could be adversely
affected by exposure to field strain B.
abortus or serve as a reservoir for B.
abortus strains in general. In addition, we
also hoped to gather information regard-
ing the potential of Richardson’s ground
squirrels to serve as a model for brucel-
losis using an attenuated strain as a
surrogate for virulent strains. Such a
model would be helpful as another
screening tool for vaccines and treatments
for brucellosis while avoiding the high
costs of a biosafety level three facility. In
the present study, we orally infected one
group of nonpregnant Richardson’s
ground squirrels with sRB51, two groups
of ground squirrels with B. abortus
vaccine strain 19 (s19) at two dose levels,
and two groups with field strain 9941
(s9941) at two dose levels. Strain 9941 was
originally isolated from an infected cattle
herd in the GYA, the source of which was
attributed to wildlife. We followed these
squirrels over the course of 14 and 18 wk
after infection. We aimed to determine
whether oral inoculation of B. abortus
could induce disease in Richardson’s
ground squirrels, if shedding of particular
strains occurred after ingestion, and to
investigate the duration of persistence of
the three strains after infection.
Forty-one wild Richardson’s ground
squirrels were obtained from Roundup,
Montana, USA (46.445uN, 108.541uW), in
June 2004. Squirrels were captured in
Tomahawk 48.3317.1317.1 cm single-
door traps and transported to an indoor
laboratory animal facility at the US
Department of Agriculture (USDA), Ani-
mal and Plant Health Inspection Service
(APHIS), National Wildlife Research Cen-
ter (NWRC), Fort Collins, Colorado,
USA. On arrival, all animals were
weighed, treated with ivermectin (0.1 mg
by mouth; Ivomec, Meriel, Deluth, Geor-
gia, USA), and given a topical insecticide
dust (Drione Insecticide, Bayer Environ-
mental Laboratories, Montvale, New Jer-
sey, USA). At NWRC, squirrels were held
under a 2-wk quarantine period upon
arrival. Two weeks after arrival, 10 squir-
rels were transported from NWRC to a
biosafety level three (BL-3) animal facility
at the USDA, Agricultural Research Ser-
vice, National Animal Disease Center
(NADC), Ames, Iowa, USA. Squirrels
were housed in standard 26.7348.33
20.3 cm plastic rat cages. All squirrel
housing, care, and experimental proce-
dures were approved by the NWRC and
the NADC Institutional Animal Care and
Use Committee guidelines. Total acclima-
tion time for the NWRC animals prior to
inoculation was 26 days. The 10 animals
taken to NADC acclimated there for
18 days prior to inoculation.
Brucella abortus strain RB51 and strain
19 used in this experiment were commer-
cial vaccine strains obtained from Color-
ado Serum Company, Denver, Colorado,
USA. Strain RB51 and s19 were reconsti-
tuted and diluted to desired concentra-
tions with the provided manufacturer’s
diluent. Brucella abortus strain 9941 was
grown on tryptose agar and harvested after
48 hr by aspiration using saline. The
suspension was adjusted by use of a
spectrophotometer (Bausch and Lomb,
Rochester, New York, USA) to the desired
concentrations. Actual concentrations of
viable bacteria within inoculums were
determined by serial dilution and standard
plate counts.
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Animals were randomly assigned to
treatment groups stratified by sex. At
NWRC, 10 squirrels were orally inoculat-
ed with 63108 cfu sRB51, six squirrels
were inoculated with 2.53107 cfu s19, 10
squirrels received 2.53104 cfu s19, and
four squirrels were given vaccine diluent
provided by the manufacturer. One squir-
rel that had been assigned to the higher-
dose s19 group had to be euthanized prior
to inoculation due to illness. At the NADC
BL-3 animal facility, five squirrels were
orally inoculated with 1.33106 cfu s9941,
and five squirrels were inoculated with
2.093108 cfu s9441. Each squirrel re-
ceived 250 ml of inoculum directly into
the mouth via tuberculin syringe. All
squirrels were observed twice daily for
clinical signs for 21 days and once daily
thereafter.
Prior to inoculation, and at 4, 8, and
13 wk postinoculation, whole blood was
collected from animals inoculated with
sRB51 and s19 only. Up to 0.5 ml of blood
was collected via the femoral or saphenous
vein using a 0.5-ml insulin syringe, and
blood was allowed to clot in a 0.5-ml
polypropylene microcentrifuge tube (USA
Scientific Inc., Ocala, Florida, USA).
Blood was centrifuged at 8,900 3 G for
20 min (Eppendorf 5415D, Brinkmann,
Westbury, New York, USA). Clots were
stored in polypropylene tubes at 280 C
until bacterial analysis. Due to logistical
reasons, blood collection was not per-
formed in squirrels housed at NADC.
To fulfill biosafety requirements at
NWRC and to collect shedding data, cage
litter swabs were collected from cages on
days 3, 6, 9, 13, 17, and 22 PI. Rectal
swabs were collected from two randomly
selected squirrels from each of the three
inoculated groups on the above days as
well. All swabs were directly plated on
Kudzas Morse (KM) agar within 2 hr of
collection and incubated at 37 C with 5%
CO2 for 72 hr. Plates were placed at 4 C
until analysis. Plates were observed for
growth of Brucella, and any suspicious
colonies were analyzed by polymerase
chain reaction (PCR). Shedding data were
not collected from squirrels housed at
NADC.
At 14 wk PI, 15 animals representing all
four groups housed at NWRC were placed
under isoflurane anesthesia, euthanized
with CO2, and bled postmortem via
cardiac puncture. These blood samples
were centrifuged at 2,800 3 G for 20 min
in a Beckman CS-6R Centrifuge (Beck-
man Coulter Inc., Fullerton, California,
USA). Animals were then necropsied,
during which pharyngeal lymphoid tissue,
lung, heart, liver, spleen, kidney, mesen-
teric lymph nodes, and reproductive tract
(testes, accessory sex organs, uterus, and
uterine horns) were taken for culture and
histopathology. At 18 wk PI, the remain-
ing 15 animals at NWRC and all the
animals inoculated with s9941 at NADC
were euthanized and processed as de-
scribed already. Samples collected for
culture were placed in sterile plastic
Whirl-Pak sampling bags (Nasco, Ft.
Atkinson, Wisconsin, USA) and stored at
280 C. Frozen specimens collected at
NWRC were sent on dry ice to the NADC
for bacteriologic evaluation. Samples col-
lected for histopathologic examination
were placed in 10% neutral buffered
formalin and sent to the National Veter-
inary Services Laboratories (Ames, IA,
USA) for histologic processing. Special
staining (Giemsa, Gram, and Grocott’s
Silver) of formalin-fixed tissues was per-
formed when lesions were identified to
determine presence of B. abortus or other
organisms.
Tissues and blood/blood clots collected
for culture were allowed to thaw, and
tissues were weighed and ground in glass
tissue grinders with 2 ml of phosphate
buffered saline (PBS). Two-hundred mi-
croliters of the resulting fluid were placed
on each of three plates containing selec-
tive media for B. abortus (KM, tryptose
agar with 15% heat-inactivated bovine
serum albumin, and brilliant green B132;
Hornsby et al., 2000). The plates were
incubated at 37 C with 5% CO2 and
SHORT COMMUNICATIONS 191
monitored for growth. The presence of
Brucella spp. was confirmed using PCR, as
described next.
A Brucella spp. PCR based on that of
Bricker and Halling (1995) and described
in Januszewski et al. (2001) was performed
to verify isolation of B. abortus. Briefly,
selected colonies were picked into 196 ml
of sterile double-distilled water. Five
microliters prepared sample were used in
the PCR reaction (50 ml total). Polymerase
chain reaction was performed using a
DNA thermalcycler (iCycler, Biorad, Her-
cules, California, USA; or MJ Research
Inc., Watertown, Massachusetts, USA)
and AmpliTaq GoldH DNA Polymerase
(Applied Biosystems, Foster City, Califor-
nia, USA). Positive controls consisted of
sRB51 and s19 bacteria. Ten microliters of
reaction products were size fractionated
through a 2% agarose gel (Sigma, St.
Louis, Missouri, USA) in 1X TAE buffer
(40 mM Tris acetate, 1 mM EDTA) and
analyzed after staining with acridine
orange (Molecular Probes, Inc., Eugene,
Oregon, USA) or ethidium bromide.
None of the swabs taken from cage
litter was positive for Brucella spp. for any
of the six time periods during which cage
samples were taken. Two of six rectal
swabs taken on day 2 PI from animals
inoculated with 2.53107 cfu s19 grew
Brucella spp., confirmed by PCR. No
other rectal swabs were positive through-
out the remainder of the 3-wk sampling
period.
One animal inoculated with 2.53104
cfu s19 was culture positive on both spleen
and pharyngeal lymphoid tissue at 14 wk
PI, and two animals inoculated with
2.53107 cfu s19 were culture positive on
mesenteric lymph node and lung samples,
respectively, at 14 wk PI. One squirrel
inoculated with 2.093108 cfu s9941 was
positive on blood culture at 18 wk PI. One
sRB51-inoculated animal was positive on
pharyngeal lymphoid tissue at 18 wk PI. A
summary of these data can be found in
Table 1.
On examination, all squirrels displayed
copious subcutaneous and abdominal fat
and had markedly enlarged, pale livers. All
livers displayed hepatocellular vacuoliza-
tion with a pronounced centrilobular
pattern consistent with lipidosis. Livers
of two squirrels had small, multifocal areas
of pleocellular infiltrates consisting of
small and large mononuclear cells, sug-
gesting mild hepatitis (2.53104 cfu s19,
n51; 2.53107 cfu s19, n51). One animal
in the sRB51 group had focal necrotizing
hepatitis.
Other lesions observed in these animals
included pyogranuloma in the kidney
(2.53104 cfu s19, n51), focal necrotizing
pancreatitis (sRB51, n51), multifocal in-
terstitial nephritis (sRB51, n51; 2.53104
cfu s19, n52), focal nephrosis (2.53104
cfu s19, n51), and two animals had sparse
mononuclear cellular infiltrates in the
lumen of the oviduct and uterus (sRB51,
n52). None of the lesions found in any of
the squirrels could be attributed to B.
abortus infection based on culture and/or
special staining.
Our study indicates that Richardson’s
ground squirrels experience minimal clin-
ical signs and pathology associated with
TABLE 1. Number of animals positive for Brucella abortus at 14 and 18 wk postchallenge over total number
of animals tested.
Time point
(wk)
Brucella abortus strain (dose)
sRB51
(63108 cfua)
s19 low dose
(2.53104 cfu)
s19 high dose
(2.53107 cfu)
s9941 low dose
(1.33106 cfu)
s9941 high dose
(2.093108 cfu)
Control
(diluent)
14 0/5 1/5 2/3 na na 0/2
18 1/5 0/5 0/3 0/5 1/5 0/2
a cfu 5 colony forming units.
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oral ingestion of field or vaccine strains
of B. abortus at challenge levels ranging
from 2.53104 cfu to 63108 cfu. We in-
tentionally used a one-log-higher dose for
sRB51 than that used by Januszewski and
others (2001) in order to increase our
chances of inducing persistent infection.
The target s19 and s9941 dose rates for the
present study were based upon traditional
challenge doses (13107 cfu) of virulent B.
abortus. While the s9941 doses achieved
target levels, we failed to do so with the
s19 doses, which we intended to be at
13106 cfu and 13108 cfu for low and high
dose, respectively. Despite the fact that
this study did not evaluate s19 infection in
ground squirrels at intended challenge
levels, this information still alleviates
concerns that this species could be se-
verely impacted by B. abortus infection
with either attenuated or virulent strains
of B. abortus.
Although a typical oral vaccine dose
could reach as high as 131011 cfu, we
elected to use the lower doses to avoid the
possibility of high mortality rates during
our experiment in order to collect long-
term data. Based on our observations
however, dose rates of 131010 or 1011
cfu probably would not have produced the
severity of disease that we initially expect-
ed. If a live B. abortus strain were to be
proposed for use in the field as an oral
vaccine, however, safety trials at the
higher dose levels would need to be
considered with the vaccine strain.
There was a general lack of persistence
of the three strains of B. abortus in
Richardson’s ground squirrels at 18 wk
PI. It is unknown if and when the three
animals that were culture positive at 14 wk
and the two positive animals at 18 wk may
have cleared the infection if given more
time. As we could not detect any evidence
of shedding of sRB51 or s19 beyond
2 days PI, and only two of the 25 animals
cultured at 18 wk showed evidence of
persistent infection, our data suggest that
even if infected, ground squirrels are
unlikely to be severely affected by B.
abortus or serve as sources of Brucella in
the field.
Our results indicate that the Richard-
son’s ground squirrel would not serve as a
satisfactory model for brucellosis based on
our oral inoculation trial. Not only did
these animals not experience disease due
to infection by sRB51, or the more
virulent s19, Richardson’s ground squir-
rels also do not appear to be susceptible to
field strain B. abortus. Wild rodents
throughout the world have been used as
models for evaluation of infection and
persistence of various Brucella species
(Gorban and Grekova, 1978; Miller and
Neiland, 1980; Cook et al., 2001); howev-
er, susceptibility to Brucella spp. infection
varies greatly among rodent species, and
there is currently no known rodent model
utilizing attenuated strains of Brucella.
Miller and Neiland (1980) found that
Arctic ground squirrels (Citellus parryii)
were readily infected by intraperitoneal
(IP) B. suis biovar 4, but they did not
experience significant pathologic changes;
lemmings (Dicrostonyx spp.) did develop
significant disease. Deer mice (Peromys-
cus maniculatus) inoculated both orally
and IP with approximately 13108 cfu
sRB51 were able to clear infection by
9 wk and exhibited no clinical signs (Cook
et al., 2001; Januszewski et al., 2001).
Comparable results have also been seen in
inbred BALB/c mice, wherein oral and IP
administration of 106 to 108 cfu sRB51
could only induce tissue persistence rang-
ing from 4 to 8 wk. This is in contrast to
virulent strain 2308, which persisted for at
least 20 wk subsequent to IP inoculation
in BALB/c mice, a commonly used inbred
strain of laboratory mice (Stevens et al.,
1994, 1995). Although Richardson’s
ground squirrels do appear to have greater
persistence of B. abortus strains after oral
infection, in comparison to some rodent
species, this persistence is not of a
consistent nature or of adequate duration
for use as a laboratory infection model.
In summary, B. abortus strains RB51,
19, and 9941 do not produce disease in
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nonpregnant Richardson’s ground squir-
rels when given orally at challenge doses
ranging from 2.53104 cfu to 63108 cfu.
Although Richardson’s ground squirrels
seem to harbor B. abortus for a slightly
longer period of time in comparison to
some other rodent species, our data
indicate that this species is unlikely to
act as a reservoir or source of infection for
either vaccine or wild type strains of B.
abortus. Based on these results, the
Richardson’s ground squirrel would be a
poor model for oral Brucella infection as
well. These data provide useful informa-
tion for researchers and those charged
with the management of brucellosis in
wildlife in the GYA.
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